Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978560 · ClinicalTrials.gov registry record
Indocyanine Green Tissue Perfusion Monitoring
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 15
- Enrollment target
NCT02978560 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 15 participants.
The verdict
NCT02978560 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The aim of this project is to demonstrate that fluorescence-mediated photoplethysmography (FM-PPG) is capable of routinely acquiring the tissue perfusion data sufficient to detect and monitor skin tissue perfusion anomalies.
Interventions
- DIAGNOSTIC_TEST fluorescence-mediated photoplethysmography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2018-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02978560
The ClinicalTrials.gov registry entry for NCT02978560 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluorescence-mediated photoplethysmography is the first listed.
NCT02978560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02978560 about?
NCT02978560 is a clinical study titled "Indocyanine Green Tissue Perfusion Monitoring". The aim of this project is to demonstrate that fluorescence-mediated photoplethysmography (FM-PPG) is capable of routinely acquiring the tissue perfusion data sufficient to detect and monitor skin tissue perfusion anomalies.
What is the current status of trial NCT02978560?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-03-05. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT02978560?
The interventions under investigation include: fluorescence-mediated photoplethysmography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02978560?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.